Abstract. The Animal Breeding Research Organisation in Edinburgh (ABRO, founded in 1945) was a direct ancestor of the Roslin Institute, celebrated for the cloning of Dolly the sheep. After a period of sustained growth as an institute of the Agricultural Research Council (ARC), ABRO was to lose most of its funding in 1981. This decision has been absorbed into the narrative of the Thatcherite attack on science, but in this article I show that the choice to restructure ABRO pre-dated major government cuts to agricultural research, and stemmed from the ARC's wish to prioritize biotechnology in its portfolio. ABRO's management embraced this wish and campaigned against the cuts based on a promise of biotechnological innovation, shifting its focus from farm animal genetics to the production of recombinant pharmaceuticals in sheep milk. By tracing interaction between government policies, research council agendas and local strategies, I show how novel research programmes such as genetic modification could act as a lifeline for struggling institutions. I wish to thank Miguel García-Sancho, Dominic Berry, Robert Bud, Clare Button, Andrew Clarke, Isabel Fletcher, Nick Hopwood and Steve Sturdy for their thoughtful comments on various drafts, as well as the two anonymous peer reviewers for their generous and highly constructive feedback. Grahame Bulfield kindly shared his memories and expertise during this project, and Clare Button and Peter Hurrell offered much-appreciated assistance with the Roslin Institute and BBSRC archives respectively.
however, suggests a more complex picture, and shows strong continuities with the policies of the 1970s. By paying attention to the interplay between macro and micro levels, this paper explores how governance can change research direction at a given place. Furthermore, while there had long been interactions between the farm and the clinic, the reforms at ABRO happened during the transition to the biotechnological mode of doing agricultural science, where consumers and innovative companies rather than farmers became key stakeholders. 4 The figure of Margaret Thatcher is symbolic of the dramatic transformation of British life in the 1980s, and it is tempting to see changes at ABRO as an application of Thatcherite policies to a research institute. 5 Yet, while agricultural research suffered greatly during Thatcher's tenure, the ABRO story does not fit this frame comfortably. First, the reorganizations were a consequence of the 1971 customer-contractor policies initiated by Lord Rothschild, head of Edward Heath's Central Policy Review Staff, and implemented in a way that proved unstable a decade later. Second, the decision to heavily curtail ABRO research in 1981 pre-dated serious cuts to the ARC's budget, albeit by months, not years. There was an element of anticipating future austerity, yet the decision was largely driven by the ARC's wish to free funds to invest into new high-priority areas: plant nutrition, animal health and especially biotechnology. Facing this decision, some at ABRO saw the crisis as a way to promote their research agendas and loosen the organization's reliance on breeding experiments, favouring instead reproductive physiology and the introduction of molecular genetics. For the new management at ABRO, the obsession with biotechnology became a lifeline as they decided to appeal to the ARC by promising a significant programme of animal genetic engineering, and delivered impressive results within a decade.
US-focused histories of biotechnology in the 1970s and 1980s tend to emphasize the importance of enterprise, commercialization and private investment in the conduct of research. 6 The role of US federal government was limited to regulating (and deregulating) Press, 1998 , a collection of papers on the history of biotechnology, is also indicative here, even though some papers highlight the role of the state. For a study of British biotechnology told from an amid concerns about safety, and to creating a climate for the new industry, notably through intellectual-property legislation. 7 Studies of biotechnology in the UK, by contrast, have uncovered an alternative approach from the British state that focused less on intellectual-property protection and more on government support and investment. 8 The story of ABRO and its successors offers a hybrid of these accounts. Government funding -and its withdrawal -were crucial in setting up the biotechnology programme at the organization. At the same time, ABRO sought alternative links and a more stable income in conjunction with industrial partners. ABRO pursued patents and entered an agreement with a private Scottish company, PPL Therapeutics, which licensed technologies in exchange for research support. Pushed both to build industrial links and to pursue more 'basic' or 'fundamental' research, ABRO used genetic modification to develop a niche that answered both demands.
This article proceeds chronologically. I begin by discussing the major changes to science funding that took place in 1972 as a result of the Rothschild report, which greatly affected the ARC. The next section discusses the ARC's financial position in the early years of the first Thatcher government, and explains its decision to heavily curtail ABRO research. The following section examines ABRO's response to the cuts and its campaign of resistance to the council's decision, which resulted in a 50 per cent settlement and a change of outlook. I then explore the adoption of molecular biology as a promising research agenda. The final section traces the further cuts to the ARC and ABRO's decision to complement its state funding with private support for genetic engineering work.
ABRO, the ARC, and the Rothschild report
The UK Agricultural Research Council (ARC) was set up by Royal Charter in 1931, incorporating a number of pre-existing agricultural research institutions. Its mission was to centralize agricultural research driven by 'pure' science, with funding decisions made by scientists. Modelled on the Medical Research Council, the ARC enjoyed extensive autonomy and received its funds directly from the Department of Education and Science, in an annual allocation commonly known as the 'science vote'. The arrangement followed a battle with the Ministry of Agriculture and Fisheries, which had campaigned for research closely aligned with governmental agricultural policy, under ministerial supervision. 9 The 1956 Agriculture Research Act cemented the ARC's autonomy from the ministry in choosing which research it funded. Despite its mission of pursuing pure science that could then be extended to agricultural practice, the ARC also funded what was recognized as a healthy applied-science programme. 10 Still, the council remained only a part of the byzantine agricultural research structure in Britain. Private R & D aside, the Ministry of Agriculture, Fisheries and Food, as it became in 1955, had its own, more problemoriented, bodies around the country with a focus on extending scientific advances to farmers, known jointly as the National Agricultural Advisory Service. 11 Furthermore, the Department of Agriculture and Fisheries for Scotland enjoyed a certain autonomy and had yet another network of research sites.
Despite Scottish autonomy in funding agricultural research, the ARC set up its own institutions there, managed from London. In 1945, the National Animal Breeding and Genetic Research Organisation was established in Edinburgh as a research institution and an advisory body for farmers, and was renamed the Animal Breeding Research Organisation in 1951. The aim was to build on the animal breeding expertise already present in the city, mostly concentrated within the Institute of Animal Genetics set up by James Ewart and F.A.E. Crew after the First World War. 12 ABRO soon started a considerable research programme, joining the ARC's portfolio of research institutes, each focusing on a specific agricultural area. ABRO's mission was to bring the knowledge of animal genetics to farmers, assess breeding techniques and conduct its own crosses on experimental farms, working with pigs, sheep and cattle. While not part of the University of Edinburgh, the organization maintained connections with geneticists there, aided by its 1964 move to a new headquarters at the King's Buildings, the university's science campus in the city's southern suburbs. Like other ARC institutes, ABRO received a block grant that enabled planning and infrastructure for long-term experiments following farm animals through many generations of breeding and experimentation ( Figure 1) .
As funding for science grew in the 1950s and 1960s, the scope of work at ABRO expanded. While most focused on quantitative genetics, the institute also attracted expertise in immunology, wool research, animal physiology and pathology, adding laboratories to complement the mostly desk-based quantitative research. By 1970, it had become a healthy research body comprising nineteen senior scientists and running seven experimental farms: five in Scotland, one in England and one in Wales. Some projects were small and resembled university research on a short grant cycle. At the same time, large-scale and ambitious experiments were being initiated in the 1970s: the Hereford project, set to examine selection and physiological genetics of this popular cattle breed; and the multibreed project investigating genetic variation within and between cattle breeds, exploring the benefits and costs of interbreeding. 13 During the expansion, a cultural division emerged between the largely office-based 'breeders' and the laboratory-oriented 'geneticists', and while they coexisted happily in the years of plenty, tensions would emerge at a time of crisis. 14 Still, ABRO's focus on productivity, combined with building wide-ranging expertise in farm-animal biology, was consistent with the ARC's post-war mission to improve agriculture through science, ensuring that Britain would never need to face rationing again.
The tensions between the ARC and MAFF persisted through the 1960s, as the ministry never gave up its plans to take over control of agricultural research. In 1970, MAFF's frustration resulted in the setting up of the Osmond Committee at the Civil Service Department, to investigate the option of bringing the ARC under ministerial control. 15 This tension triggered two further reviews that ended up bringing striking change to the landscape of British science policy and funding. The first study, by the Council for Scientific Policy within the Department of Education and Science, concerned the relationship of research councils with the state. It was led by Sir Frederick Dainton, a chemist and the Council for Scientific Policy's chairman. The Dainton inquiry started in 1970, shortly after the Conservative Party under Edward Heath had won the general election, on a platform of liberating British enterprise and cutting inefficiencies in spending. As part of his agenda, Heath sought to transform government machinery towards more rational and evidence-based policy making. Shortly after moving to 10 Downing Street, he introduced a new body to advise the Cabinet, independent of ministries and departments and responding directly to the prime minister. Officially called the Central Policy Review Staff, it was headed by Victor Rothschild, 3rd Baron Rothschild. The body soon became known as 'the Think Tank'. 16 As one of its first tasks, the Think Tank was charged with reviewing the way government departments and ministries commissioned and managed research, going beyond the Dainton inquiry. 17 Both reports were eventually published under the same cover in November 1971 as a Green Paper, a draft policy to be discussed. The White Paper, official government policy based on these reports, appeared in July 1972. Together, they made for a curious read. Dainton's tone was level-headed and mundane; he found the system largely satisfactory, if slow to respond to changing circumstances, and recommended a new body to coordinate between the councils. Rothschild's report, by contrast, was universally recognized as provocative, written in lively, pugnacious prose that Nature described as 'a kind of racy telegraphese'. 18 Rothschild's crucial argument was that scientists and research council bureaucrats, no matter how well intentioned and knowledgeable, were not the people to decide what kind of research the country needed. Rather than trust scientists to come up with most useful directions, Rothschild left the decision to ministries and departments, the ultimate stakeholders. Applied science was to be funded on a customer-contractor basis, i.e. the government customer would commission specific research, and a research body would carry it 15 Miles Parker, 'The Rothschild report (1971) Rothschild's stance offered a sharp and deceptively naive division between 'pure' and 'applied' research. As historians of science have shown, the boundaries between those categories and the very way of defining them have been historically specific, often controversial, and politically driven. 19 Many of Rothschild's contemporaries saw sharp distinctions as unhelpful and problematic, while the critics of his report appealed to the unity of science and the unpredictability of useful applications that could come out of research envisioned without practical aims. Rothschild, by contrast, contended strongly that the needs of the country were too 'urgent and identifiable to rely on chance discoveries -to warrant those needs being left to a form of scientific roulette'. 20 'Pure' or 'basic' research was spared, as Rothschild did not appear to consider it was up for negotiation and left it to the Department of Education and Science to fund. In his proposal, research councils would also contribute to what he called 'general research' -that is, long-term work with no clear outcomes but of potential relevance to future practical needsthrough a 10 per cent surcharge paid by the relevant customer.
Rothschild's role and connections to the prime minister gave his analysis much weight with the Cabinet, and his customer-contractor principle became official policy in 1972. Subsequent governments defended it as sound throughout the 1970s and 1980s. For research councils, the new policy meant that parts of their funding moved from the science budget to a government department that came closest to constituting a customer. Thus the Department of Health and Social Services took over some of the MRC funding, but the MRC managed to reverse the arrangement in the early 1980s. 21 The ARC, on the other hand, ended up as the key subject of the policy experiment. 22 About half of the ARC's budget moved to MAFF as its customer -less than Rothschild would have wanted, but dramatic enough (see Figure 2) .
The Rothschild report recommended that ABRO should be funded by an ARC block grant from the science vote, without MAFF commissions. This also applied to the Babraham Institute of Animal Physiology and the plant physiology Letcombe Laboratory in Oxfordshire, as all three sites pursued 'strategic' research that had no 19 On pure/applied research and various other definitions see Robert Bud, 'Framed in the public sphere: tools for the conceptual history of "applied science" -a review paper', History of Science (2013) clear applied objectives but was deemed useful. 23 Strategic research -defined by Rothschild as science designed to develop new applied programmes -become an important category in future discussions about the place of ARC-funded science, especially biotechnology. Yet these recommendations were not adhered to, and the three institutions received mixed ARC/MAFF funding. Some 68 per cent of ABRO's budget moved to MAFF commission. 24 In the implementation of Rothschild's policy such alterations were common, a result of political expediency and considerable resistance from scientists and scientific bureaucracies, within and beyond the research councils.
In 1974, ABRO's retiring director, H.P. Donald, wrote a piece for the annual report, responding to the recent bureaucratic changes. Titled 'New tasks for livestock genetics', it argued that 'old meaningless phrases about helping farmers and raising efficiency will scarcely serve now'. 25 Instead, Donald urged ABRO staff to engage more with agricultural policy and industry -not as Rothschild-style contractors, but as consultants who could clarify ill-defined and poorly formulated criteria through scientific theorizing, steeped in genetics. Donald's argument implied that ABRO should embrace theoretical investigations and engage with farming problems.
The ARC did not leave much time for its scientists to act as consultants, but did impose similar expectations in terms of balancing research priorities. ABRO was to pursue both fundamental work of high scientific merit and research with practical applications. The organization was audited every four to six years through the system of visiting groups, composed of senior agricultural scientists, biologists and farmers, who assessed the workings of the institute and the science performed there. The 1974 visiting group at ABRO suggested several changes, notably division of the rigid vertical structure into departments arranged by discipline (see Table 1 ). Furthermore, the group recommended withdrawing from attempts to produce new breeds, leaving those to the farmers. These recommendations presented the difficult balance the organization had to achieve, as it now had two funders to placate: That ABRO's principal concerns should be with research directed towards genetic improvement of farm animals … [and with ensuring that] that the Institute [has] competence in relevant basic research; and that while retaining a capability to evaluate the practical validity of the results in its research, the Institute should not put direct effort into developing new varieties of farm animals. 26 Under Harold Wilson and James Callaghan's troubled Labour governments (1974-1979), Rothschild's ideas continued to be slowly implemented. The Rothschild arrangement splitting pure and applied research appealed to neither MAFF nor the council, and both were eager to avoid sharp cut-offs between the two kinds of science. In order to decide what research might be necessary to contract, the ARC, MAFF and the Department of Agriculture and Fisheries of Scotland set up a Joint Consultative Organisation that started operating in 1973, with five boards dedicated to major agricultural sectors. Each board consisted of between two and six more focused committees, asked to rapidly review the needs in their sectors. In 1975, all boards largely endorsed the status quo, as they argued that British agricultural research had been relevant to farming needs all along. 27 But the organization also used the opportunity to offer recommendations about promising areas of research. For instance, the Animal Board proposed the following:
Plant breeders are making use of techniques which allow the production of species hybrids and the transfer of relatively specific genetically controlled traits from one species to another. Research on cell and tissue hybrids in animals has for various reasons not reached the same level of advancement and it is recommended that such work should be given some support at the strategic level. 28 To elaborate on such recommendations, and to make a stronger case for the science vote funding, the Priorities Working Party was established in 1976, comprising ARC and ministry representatives alongside scientists. 29 In its first report, focusing on plants, the working party recommended several scientific areas of great importance, including nitrogen fixation in soils, studies of photosynthesis and genetic manipulation of crops. 30 A year after the report was published, Ralph Riley became the new secretary of the ARC (the scientific director balanced by a non-academic chairman). Riley had worked as a molecular biologist at the Plant Breeding Institute in Cambridge, taking over as director in 1972, and had a clear interest in adapting molecular techniques to plant agriculture. 31 Radical changes to science funding presented the ARC with new possibilities. Shared opposition to Rothschild's policy improved the council's relationship with MAFF and allowed the two bodies to articulate new priorities for future research. 32 MAFF developed its own chief scientist's office and staff, charged with assessing commissioned work, in line with the Joint Consultative Organisation's recommendations. For institutes like ABRO, the benefits were less clear, as MAFF's system of monitoring remained unsettled and threatened interruptions; moreover, the ministry's financial commitments could be withdrawn much more rapidly. Thus, by 1979, MAFF's contributions dropped from 68 per cent to 40 per cent, leaving the ARC to cover the balance. In a 1979 review of the Rothschild framework and its implementation, the Public Accounts Committee criticized the uncertainty and lack of flexibility that research councils now faced. At the same time, it lauded the collaboration between government departments -now 'customers' -and the councils, and suggested that greater efficiency would be achieved over time.
The ARC and Thatcher's first government Rothschild had left the Think Tank in 1974, but subsequent governments continued to consult him in an informal capacity, especially Margaret Thatcher's. He was not impressed by how the research councils had interpreted his model. In a 1983 letter to Thatcher, he complained,
The scientific community strongly disapproved of my recommendations, and I believe the A.R.C.'s way of impeding their implementation was to set up so cumbersome a bureaucratic machine, ostensibly to implement them, as to make it almost certain that little would happen. 33 Thatcher's reply was sympathetic. She wrote back, saying agricultural research was in 'an appalling state of affairs which simply must be dealt with'. 34 Thatcher had been very familiar with the Rothschild report and its implications -she had been the Education and Science Secretary in Heath's government, although the changes to science policy often happened behind her back. Indeed, in line with her portfolio, she had defended scientific interests and had opposed the customer-contractor principle that ended up becoming official policy. 35 Much had changed since her time in the Heath government, however. In 1979, Thatcher swept to victory in the general election. As Britain faced dramatic inflation, reaching 18 per cent in 1980, her government embarked on a programme of cuts.
In its early days, however, the Conservative government took it upon itself to protect the science vote. Before its electoral defeat, the Callaghan government had given the ARC a modest increase of £300,000 in 1979 to implement the advice of the Priority Working Party and to hire scientists to work on genetic modification of plants in three of its plant research institutes. 36 The first year of the Conservative government brought modest cuts that the council could absorb, although it did begin preparing for decreased public spending in the future. 37 In 1980-1981, there was a further mismatch between funding allocation and growing real-term expenses, to which the ARC responded by refusing to refill a number of vacant posts, and by introducing an earlyretirement scheme. 38 When the expected science vote allocations for 1981-1982 were announced in February 1981, Nature celebrated the research councils' 'getting off lightly', with small increases in funding. 39 Thus the ARC received a £3 million increase to its budget, although much of this was to be spent on growing salary commitments stemming from inflation. There were crucial changes, however, in how the new government planned public expenditure. Instead of volume purchases -specific spending goals that could be adjusted for salary costs and inflation -the budget was planned in cash, as finite sums. 40 The ARC's pre-existing commitments were greater than the money available, mostly due to salary increases (committed 7.5 per cent versus budgeted 6 per cent). 41 As a result, the council had to find more substantial savings. Besides balancing its books, the ARC was also responding to its own wishes, articulated by the Priorities Working Party, to refocus its efforts on more basic and high-profile areas of research, including biotechnology.
Biotechnology was becoming an epitome of high-tech industry where national scientific clout could translate into global leadership and growth. Many historians have argued for the continuity of the 'new' biotechnology, based on the set of tools known as recombinant DNA developed in the early 1970s, with older fermenting and chemical industries. 42 While the revolutionary impact of genetic engineering has been overstated by many, new biotechnology brought dramatic transformations to the life sciences, expanding industrial links, developing patenting practices and establishing scientists' ability to benefit financially from their discoveries. US universities and start-ups such as Genentech and Cetus led the way, and after the dramatic 1970s debates around the safety of recombinant DNA were neutralized, British scientific and political establishments were keen to get involved. 43 Crucial in setting out the course for British biotechnology was the Spinks inquiry started by the Labour government in 1978. Headed by Alfred Spinks, the former director of research for Imperial Chemical Industries, it was a collaboration between the Royal Society, the Advisory Council for Applied Research and Development, and the Advisory Board for the Research Councils. The Spinks report noted that biotechnology straddled the divide between basic and applied research, and argued that as 'strategically applied research' it was ill-served by the research council system. 44 It therefore encouraged wide-ranging collaboration, with the Science and Engineering Research Council (SERC) and MRC becoming key sponsors, and a considerable role also envisioned for the ARC. While ideal inter-council cooperation was never quite achieved, biotechnology experienced great expansion in Britain in the early 1980s, with considerable state support. 45 Combining a budget strain with an imperative to free new funds for biotechnology, the ARC was unwilling to make an across-the-board cut in its expenditure. University grants only made up about 4.5 per cent of the ARC's expenses, and there was a strong incentive to protect those. Instead, it decided to make major savings, couched in the language of 'flexibility and structural change', by severely curtailing research at two institutions -the fruit research arm of the Long Ashton Research Station near Bristol, and up to 80 per cent of work at ABRO. The decision was announced in a press release on 11 December 1981. The ARC justified cuts at Long Ashton by arguing that fruit research was already well supported beyond its economic impact. 46 The reasons for choosing ABRO were more elaborate. The official line was that, while ABRO had delivered much important science in the past, there was little need for long-term large-scale breeding experiments in the future -that they could be managed by smaller groups at universities, while ABRO itself should focus on its strengths, such as reproductive physiology, employing a much reduced staff. 47 Work at ABRO was far from the greatest area of expenditure for the council, sitting in tenth place out of twenty-two institutions that the ARC supported, but its budget had nevertheless raised some concerns. 48 In the first months of 1980, before any cuts were mentioned, the ARC had reviewed ABRO's farm portfolio and found it too ambitious and sprawling. The council suggested the sale of farms in Rhydyglafes, Wales, and in Cold Norton near Birmingham. While the review shows some frustration on the ARC's side, it also encouraged ABRO to replace the lost farms with land to be purchased near Edinburgh, hardly an indication of planned shut-down. Many have blamed the 1980 visiting group for the devastating outcome, but the group's report was by no means a condemnation and highlighted much positive work done there -indeed, some of the group's members subsequently expressed surprise that ABRO was singled out for cuts. 49 It should be noted, however, that even minor criticisms could be damaging, 714 Dmitriy Myelnikov and members may have shared opinions that dissented from the politesse of the written statement. Indeed, as future events suggest, the ARC leadership read the visiting group's report as rather faint praise.
The group that arrived in October 1980 was headed by John Jinks, a senior geneticist at the University of Birmingham. It also included a farmer, two agricultural scientists, another senior geneticist and Anne McLaren, by then an established mammalian developmental biologist with a strong interest in molecular biology. 50 The group took issue with ABRO's statistics service, finding that it was overwhelmed and the cause of a publication backlog. At the same time, the final report singled out the reproductive physiology department as excellent, and commended the organization's new departmental structure. The overall verdict was:
The Group is generally satisfied with the state of the Organisation and with the competence of the staff. Some areas of excellence have been identified, particularly reproductive physiology, and the Group notes with pleasure the enthusiasm and ability of younger members of staff in several departments. 51 The group did not go so far as to overturn the council's decision about decommissioning farms in Wales and England, but it did recommend construction of a mouse facility, the purchase of new farms near Edinburgh and the hiring of additional statisticians. These recommendations were supported by a visit from a senior ARC official to ABRO in February 1981, whose correspondence with the council conveyed a less optimistic picture. It emerged during the course of this visit that not all staff were happy with the costly selection experiments then dominating the research agendas: 'A wider need was identified by some senior staff, to establish a strong core of fundamental work in biology to counterbalance the present heavy emphasis on large scale, long-term selection experiments'. 52 The statistics problem seemed more dramatic, too, 'a massive imbalance between the production of data and its handling' that suggested poor management. 53 These concerns, combined with financial pressures on the ARC, led to ABRO being singled out. As I discuss below, the ARC faced far greater cuts after 1982, as well as pressures to increase support for food research and university grants. Together, these factors forced the closure, mergers and privatization of many institutes. These future cuts were part of concerted government attempts to reform agricultural research and to move more to industrial players, although the eagerness of established scientists sitting on the research councils to protect universities and have more basic science was also responsible for diverting funds away from agriculture. The cuts at ABRO are understandably often decision making. Bill Shelton, the Parliamentary under-secretary of state for education and science, was eager to place the responsibility on the ARC, and to wash the government's hands of the planned cuts: 'I assure the House that, to date and no doubt for the future, although I cannot give the figures, the ARC has been treated well financially, as I think it will acknowledge'. Shelton stressed that no decisions had yet been made, and suggested that it was the council's choice to make savings and invest in new programmes, including genetic engineering:
If this decision goes through, I again emphasise that no decision has yet been made, it is proposed to use the present institute field station at Dryden for what are described as 10 highly innovative scientists with a supporting staff of about 40 who would conduct the animal genetic experiments … The ARC made it clear in its press release that this is not a matter of cutting to reduce total expenditure but of cutting to increase flexibility and to allow new sums to be spent on new high priority work in its institutes on agricultural food, nutrition and bio-technology. 59 In response to the pressure from farming bodies, Parliamentarians and the press, the ARC introduced a consultation process and reached out to stakeholders for advice. 60 In February and March 1982, the ARC produced two documents outlining its rationale. 61 According to the first, cattle breeding work was too expensive and inflexible, and much could be saved from selling the cattle farms and focusing instead on sheep and pigs. The latter document reiterated a commitment to smaller-scale, universitybased research on animal breeding, suggesting that a much leaner ABRO should instead focus on animal genetics from an applied angle, but with sufficient capacity to include basic science where appropriate. It was, however, produced after the ARC meeting on 23 March, where the council discussed the strong opposition to the cuts and tried to alleviate them somewhat. The envisioned changes would now mean the loss of 139 jobs -sixty scientists, technicians and farm assistants, and seventy-nine administrators and farm workers not directly involved in experiments. Some posts would be freed through early retirement, but most would be lost through redundancy. While it was the council's goal to refocus on basic research, the Hereford Breeding Society weighed in with a defence of the long-term Hereford project. Furthermore, as a customer under the Rothschild arrangement, MAFF representatives objected to curtailing the research that the ministry was now funding. 62 While recruiting support from various interest groups, King proceeded to plan the future of ABRO. He requested that the heads of departments come up with a plan for maintaining the organization at 85 per cent capacity. The head of reproductive physiology, Gerald Wiener, who had worked at ABRO since 1947, defended his domain. In a memorandum to King, he argued that 'across-the-board departmental cuts are not the best way of reducing ABRO's total commitments and that in fact the emphasis on research in physiological/biochemical genetics should be strengthened at the expense of other activities'. 63 Since reproductive physiology was recognized as an excellent area of research by the visiting group, and was the presumed core of the future ABRO, Wiener ended up as a go-between liaising with the ARC. In his correspondence with Jinks and Riley, he emphasized that he wished the cuts could be avoided, but urged ring-fencing experimental work in physiology and the projects run by young scientists. In a further report to the ARC, he noted two cultures, or 'philosophies', that coexisted in ABRO: genetic improvement of breeds, in collaboration with farmers, on the one hand, and fundamental research into animal genetics on the other. He suggested that the difference between the two philosophies is significant and at the root of much of the conflict both within ABRO and with the Council. It underlies the general emphasis that has been given increasingly over recent years to the more applied experiments in ABRO in direct conflict for resources with ideas for more fundamentally oriented research. 64 Wiener saw ABRO in a fundamental research role, providing advice and close links with industry, including analysis of commercial breeding programmes with quantitative genetics, but not as a site of applied research as such.
Wiener's suggestions appealed to the ARC. As he recalled, at one of the meetings with a senior ARC representative, he had been offered the position of the new ABRO director -the council had decided to replace King. Wiener had cited his age (he had four years left until retirement) and his reluctance to preside over redundancies of colleagues as the main reasons he had declined and suggested Roger Land instead. 65 Land had joined ABRO in 1966, and worked extensively on predicting reproductive potential through physiological tests. Land's appeal to the ARC was aided by another consideration -unlike both Wiener and King, he was eager to introduce genetic engineering research at the institute. 66 In April 1982, the ARC reviewed the proposals for a heavy cut. Responding to pressure from multiple stakeholders, including MAFF, it agreed to reduce ABRO's funding by about half -from £2.2 to £1.2 million -not the original 80 per cent. The council also promised an extra fund of about £400,000 for 'important new work of high scientific merit', with genetic modification in mind. 67 ABRO's limited success in reversing some of the cuts was a result of effective networking by its director and outrage at the announcement of cuts without due warning or deliberation. Furthermore, while its financial arrangements with MAFF had been troublesome, the Rothschild system of dual support had proved a useful resource, as MAFF intervened on the organization's behalfarguably, the ARC would have had less trouble curtailing ABRO programmes before Rothschild. Beyond recruiting allies, however, the management at ABRO decided to align the organization with ARC's new priorities, specifically genetic engineering. By the end of the year, John King was appointed away from ABRO to lead the ARC's Edinburgh Breeding Liaison Group at the Edinburgh School of Agriculture, and Roger Land presided over the restructuring at ABRO, and over setting up a molecular biology programme.
Going molecular at ABRO
The issue of genetic modification was discussed by the 1980 visiting group. In fact, the suggestion came from King, in his report to the group:
One of the major problems facing ABRO for the future is to decide at what stage to develop studies of genetic engineering. Up till now all attempts to introduce new DNA into germ lines of mammals had been unsuccessful but a recent report (New Scientist, 11 September 1980, p. 763), suggests that this hurdle may have been overcome. The general idea is developing so rapidly that an appropriate animal breeding involvement now seems timely. The most suitable means of achieving this objective would be by appointing appropriately qualified staff at ABRO and then seconding them to work by arrangement in a molecular biology unit. 68 While molecular biology had its origins in the study of protein rather than DNA, and ABRO scientists had worked with other molecules such as hormones, by 1980 and in this context, 'molecular biology' meant working with recombinant DNA. 69 The 'recent report' to which King referred concerned genetically modified mice born at Yale and announced at a conference in West Berlin. 70 On top of manipulation, isolating and eventually sequencing important genes were promising avenues. The ARC's enthusiasm for the technology was palpable, as it organized a meeting on animal genetic engineering in Cambridge in October 1980, and a scientific conference in early 1981. 71 Indeed, King cited the New Scientist report because the Yale group had not published its results in a journal by that point. 72 Two years later, in December 1982, images of the giant 'supermice' made through the insertion of rat growth hormone genes into the mouse embryo made the cover of Nature and were picked up enthusiastically by the US and British press. With these animals, a real promise of genetic modification on the farm was being discussed more seriously than ever. 73 The visiting group agreed that such genetic work would be 'timely', but should start on a 'modest scale', with close links to the University of Edinburgh. Yet while King expressed enthusiasm in his report, he had strong reservations about adopting genetic engineering at ABRO, as did some of his colleagues. In a 1981 volume celebrating ARC's fiftieth anniversary, King concluded his piece on achievements in animal breeding by commenting that his 'own opinion would be less optimistic than many that have been advanced … While genetic engineering seems a most legitimate area of enquiry its practical application is likely to lie well into the next 50 years'. 74 Gerald Wiener, the head of physiological genetics at ABRO, agreed with King's assessment: 'It is an area we should keep our eyes on, but for the moment, from the outside, in spite of its trendy appeal'. 75 Roger Land, who took over the directorship, was committed to introducing molecular genetics at the organization. He went on to implement the visiting group's recommendations and in 1983 hired Richard Lathe to start a genetic-engineering programme. A University of Edinburgh graduate, Lathe had moved to France for his graduate studies to work with Pierre Chambon, a prominent French molecular biologist and a European leader in recombinant DNA research. From ABRO's perspective, Lathe could offer rare and valuable experience -he had worked for a biotech company, Transgene SA in Strasbourg. The company had been set up with Chambon's patronage and considerable state funds, and had worked on producing the recombinant vaccine for rabies that was successfully deployed in the wild. With his move to ABRO, Lathe brought new perspectives on what genetic manipulation might achieve. 76 After the dramatic images of supermice, several groups worldwide looked into extending the techniques to farm animals. The inventors of the mice, the reproductive scientist Ralph Brinster at the University of Pennsylvania and the molecular biologist Richard Palmiter at the University of Washington, initiated a collaboration with the US Department of Agriculture's (USDA) Agricultural Research Service in Beltsville, Maryland, to make transgenic pigs and sheep with growth hormone genes. 77 Lathe, by contrast, envisioned another strategy, much more in line with what biotech companies had been doing with bacteria: synthesizing valuable medical proteins. While the powerhouse of molecular biology and recombinant DNA research, E. coli, showed dramatic successes in producing insulin, human somatostatin and human growth hormone, the majority of animal proteins were difficult to synthesize in bacteria. This is where cattle and sheep came in. In a piece in ABRO's 1984-1985 annual report, Lathe wrote of the 'molecular tailoring' of animals. 78 The cover of the report proudly carried a Southern blot image (a technique invented by Edinburgh's Edwin Southern in 1973 and used to identify isolated genes) rather than the usual photograph of farm animals (Figure 3 ). Sheep could be modified with genes for useful drugs, with the hope that their expression could be targeted to their milk -an approach that came to be known as 'pharming' in the 1990s. 79 Scientists at leading sites such as the MRC's Laboratory of Molecular Biology in Cambridge were reluctant to adopt a commercial biotech outlook in the early 1980s, and persuading them to do so was a difficult process. 80 ABRO scientists could not afford such luxury. Significant resources were thrown into the implementation of genetic engineering, and Land's approach was at times heavy-handed. Ian Wilmut, a reproductive physiologist experienced in embryo transfer, was forced to abandon his project on prenatal mortality in sheep and move to the transgenic team. 81 Alan Archibald, an ABRO scientist who had gone to the European Molecular Biology Laboratory in 1982-1983 to train in recombinant techniques, was in charge of isolating and assembling the gene constructs that were to be injected into sheep and mice. 82 John Bishop, at the Department of Genetics, was a key senior collaborator, and the molecular biology group also relied on his mouse facilities at the King's Buildings site. Bishop's postdoc John Clarke took over ABRO's molecular biology programme after Lathe left Edinburgh in 1986.
While funding continued to dwindle and decline in the late 1980s, genetic engineering remained a priority. In the preface to AFRC's first corporate plan for 1984-1988 -an exercise in projecting accountability and transparency -Ralph Riley described the council's mission as providing 'fundamental science from which entirely new technologies will grow in the future'. 83 He outlined the recent changes to the funding, but also singled out opportunities -specifically that 'molecular biology, biochemistry and biophysics are providing new understanding and new potentialities for the manipulation and management of crop plants, farm animals and industrial micro-organisms'. 84 the very organization of science -'the need to introduce private funding to make up for reduced public expenditure could change the relationship between research and industry'. 86 Introducing recombinant DNA techniques proved a lifeline for ABRO, although the strategy was not unique to the institution. As discussed above, the Microbiological Research Establishment at Porton Down adopted a similar strategy when faced with the 1970s defence cuts. An appeal to promissory science, in terms of both productive future research and economic outcome, proved effective for both struggling institutions -especially during the early stages of adopting genetic engineering -driven by anxieties about Britain's place in global science and its ability to cultivate innovative research. At the same time, as Jane Maienschein has pointed out, cutting edges cut both ways, and as some research programmes are elevated, other suffer. 87 Changes at ABRO affected its identity and envisioned beneficiaries; from being an agricultural body attuned to farming needs, the institution reoriented itself towards drug production and molecular research, while its breeding research programmes declined. 
Public-private science
In response to the complex political to-and-fro, ABRO changed its core portfolio and focus, and embraced genetic engineering. In a context of agricultural overproduction, Thatcher's government saw little value in increasing productivity through science, and expected industry to pull more weight in funding research. At this time of uncertainty, the ARC identified plant biotechnology as an area that could supplement a shrinking budget. Meanwhile, ABRO also sought extra funds by entering a relationship with PPL, a private company it helped create. Yet while the changes to the organization's research agendas were largely imposed from London, its entrepreneurial story was specific to Scotland.
After cutting programmes at ABRO and Long Ashton in 1982, the ARC was facing new difficulties. In May 1981, Thatcher's government had announced severe cuts to university budgets. Since the Second Word War, Britain has implemented a 'dual-support' system for university research, with separate streams of funding from the research councils and the university 'block grants', distributed by the University Grants Committee. The block grant was used for teaching, but also to support research across the sciences and humanities. In the natural sciences, the money was often used to furnish laboratories and to support risky projects before they could receive research council or other funding. Thatcher's government decided to cut the UGC block grant heavily, generating much anxiety about the future of British science. 88 The Advisory Board for the Research Councils (ABRC), the umbrella body set up to coordinate between all councils and the government after the Rothschild reforms, responded to university cuts with alarm. Giving testimony to the House of Lords Select Committee on Science and Technology, Sir Alec Merrison, ABRC chairman and vice chancellor of the University of Bristol, criticized the UGC cut heavily, suggesting it would undermine efficiency and innovation. 89 In its 1982 recommendations, the ABRC urged Keith Joseph, the Secretary of State for Education and Science, to maintain (and ideally expand) research council support for university research. Furthermore, the board sought more money for the international commitments of the Science and Engineering Research Council, such as CERN. The ARC, with its minor university funding, saw its interests sacrificed in this process. The ABRC insisted that the council had to make savings of £3 million a year by 1985, about 3.5 per cent of its annual budget. Ralph Riley was a member of the ABRC and, in an unprecedented move, dissented from the recommendations; his response was published as an appendix to the report. 90 88 Universities were, on average, to lose 15 per cent of the block grant over three years, but a further 2 per cent cut was imposed in 1983. While the UGC cuts targeted universities as institutions -part of Thatcher's campaign to reform higher education and attack professional autonomy -one unintended consequence was a blow to university science. Geoffrey Walford, 'The privatisation of British higher education', European Journal of Education (1988) Riley's dissent had little effect; 1982 and 1983 were bad years for the ARC. Five reports to the government, while paying lip service to the customer-contractor principle, strongly criticized the way in which agricultural research was being commissioned. Most placed some of the blame on the ARC. 91 Furthermore, the council's case was misaligned with government priorities. Since 1973, the UK had been part of the European Common Market, and with it, the Common Agricultural Policy. The late 1970s and the 1980s witnessed a major crisis of overproduction in European agriculture, driving prices down and increasing subsidies. Treasury correspondence regarding the future of the ARC showed little sympathy for supporting agricultural research when it saw extreme production efficiency as part of the problem. 92 John Moore, economic secretary to the Treasury and self-styled 'Mr Privatisation', went as far as suggesting that the ARC should be privatized and act as a major contractor. This option garnered little enthusiasm from the Treasury's civil servants and generated opposition on legal grounds, since forcing the council to go private would contravene its Royal Charter. 93 The options for privatizing its institutes, on the other hand, were not ruled out, although scepticism over finding buyers was voiced.
The ARC tried to mitigate criticism by following the ABRC's call to fund more university science, and the recommendations from the Advisory Council for Applied Research and Development (ACARD) to support more food research. In 1983, the ARC changed its name to the Agricultural and Food Research Council (AFRC), to reflect the new emphasis. The government expected that the AFRC could find money through more active commercialization of research, and a state-backed Agricultural Genetics Company was set up for the purpose in 1984. It followed the example of the MRC company, Celltech, which commercialized monoclonal antibodies and other technologies developed by the council. 94 After Thatcher lambasted the failure to patent monoclonal antibodies, the responsible National Research Development Corporation was merged with the National Enterprise Board to form the British Technology Group (BTG). 95 With Celltech as a model, the BTG funded the new Agricultural Genetics Company and brought in two private players, the oil company Ultramar and Advent, a European venture capital fund set up by Monsanto. 96 The new Cambridge-based company, however, only dealt with plant genetics, leaving animal research aside.
Meanwhile at ABRO, Rick Lathe, John Bishop and John Clark envisioned the commercialization of the pharming project, in a model increasingly used by US institutions but still novel in Britain. With Roger Land, they planned to patent the key techniques, and sell an exclusive licence to a private company. Since farm animals did not fall into the remit of the Agricultural Genetics Company, ABRO management decided to tap into local developments. London and Cambridge may have taken the lead in British biotechnology, but there was also much activity in Scotland. In particular, the work on the recombinant hepatitis B vaccine by the University of Edinburgh's Ken Murray and Noreen Murray, done in association with the European biotechnology firm Biogen, was paving the way. 97 In the early 1980s, the Scottish Development Agency (SDA), a new public body set up with North Sea oil money to foster Scottish business, established a biotechnology department. Lathe approached the SDA's Iain Shirlaw, a former food scientist who had retrained at the London Business School. The SDA provided crucial seed funding and attracted venture capital from Prudential Investment Managers, an investment arm of the major insurance company, and from the Transatlantic Capital Bio-sciences Fund. The new company began as Caledonian Transgenics Ltd, and was soon renamed Pharmaceutical Proteins Ltd, or PPL. Technically, it was not a spin-off, as the AFRC institutes were then banned from owning equity in private companies. Instead, PPL was an independent firm that would license ABRO's patents and, crucially, fund some of its research, while also hiring its own scientific staff. 98 Initially, PPL set up offices and laboratories at the King's Buildings, in close proximity to the molecular biology team of the organization that it now co-funded. Besides receiving investment from PPL, ABRO benefited from letting the new company its facilities, and from charging the firm for instrumentation and overheads, and for use of farm space for the company's experimental sheep. While Roger Land acknowledged concerns about the confidentiality of commercially relevant research -which could no longer be discussed as openly as in the past -he stressed that PPL would provide a 'substantial sum which will release pressure on core funding and help the Research Station through the period of funding difficulties'. This was, moreover, 'in line with Government and AFRC policy'. 99 Grahame Thurnbull, the first CEO of PPL, claimed to appreciate the concerns of the scientists, stating that 'the absolute need … to be able to publish any future work involving the Company is well understood'. 100 After PPL hired its own team in 1988, the arrangement moved beyond investment into a long-term collaboration between the AFRC and company scientists, with much movement between the two bodies.
By the time the deal with Caledonian Transgenics/PPL was finalized, ABRO had faced another shake-up as the AFRC was forced to continue its programme of restructuring. In an attempt to save money on administration and to centralize farm animal research, Despite the cuts and painfully felt redundancies, ABRO and its successors within the IAPGR managed to secure new sources of funding. They tapped into governmental and private enthusiasm about biotechnology with results in the form of the AFRC block grants, MAFF commissions and PPL's investment. The transgenic programme in Edinburgh continued to rely on a research-institute model with its long-term grants that promised a continuity unobtainable in most university laboratories. Since the first cuts to ABRO, molecular biology research was funded through the special extra grant for new science that was part of the 1982 settlement with the ARC. In 1988, the AFRC introduced further special grants to support transgenic and stem cell research, in a funding scheme known as the Transgenic Animal Programme that was available almost exclusively to the Edinburgh and Cambridge stations of the IAPGR. 101 This diversity of sponsors created a sustained and hybrid alliance between public and private funding for animal biotechnology, which Edinburgh geneticists used to their advantage as much as they could. The transition from farm animal genetics to molecular genetics not only changed the orientation of the institute, but also allowed it to weather further policy changes, such as the 1988 volte-face on applied science that determined that any work deemed too 'near market' should be carried out privately and not in state-funded bodies. 102 By contrast, many other AFRC institutes faced closure, mergers and privatization -most notably the Plant Breeding Institute, bought by Unilever in 1987. 103 In 1981, ARC supported twenty-two institutes and research stations; by 1991, this number had come down to seven. 104 
Conclusion
In 1990, a sheep called Tracy was born at the IAPGR's Roslin site. She was the first transgenic sheep to produce significant -indeed, dramatic -amounts of a human protein in her milk. This protein was alpha-1-antiripsin, a drug for certain kinds of emphysema and cystic fibrosis. While she was born at the IAPGR, she also represented a promise for PPL to market the drug in the future. Shortly after the news of her birth, in 1993, the IAPGR was disassembled, with the Babraham Institute regaining its name, and the Edinburgh Research Station becoming the Roslin Institute. In the same year, the AFRC was merged with the biological arm of the Science and Engineering Research Council to form the BBSRC, the Biotechnology and Biological Sciences Research Council. The name change was representative of the general decline in agricultural interests as justification for basic research with strategic goals, and defined a new priority for the application of research -commercial biotechnology.
Tracy embodied a triumphant success of genetic engineering in Scotland that had seemed unlikely a decade earlier. When she died in 1996, her body was stuffed and acquired by the Science Museum in London. Shortly afterwards, Dolly the cloned sheep was announced to the world. Dolly was not genetically modified, but rather a prototype for improving the woefully inefficient production of transgenic animals by cloning sheep from successfully modified cells. 105 In Dolly Mixtures, Sarah Franklin has highlighted 'the extent to which [Dolly] results from a mixture of agricultural, commercial, industrial and medical purposes'. 106 While these interactions have a long history, their nexus took place in the 1980s, with the decline of agricultural science funding and a growing emphasis on genetic modification. ABRO was one of the earliest sites, globally, where these connections became fixed and productive, in response to sustained crisis.
It was the promise of biotechnology to the British economy that both devastated the old ABRO and allowed the station to survive in a new guise. While there had been reasons to expect ABRO's eventual move into animal biotechnology, this shift did not result from a coherent policy, but from a set of complex and contingent negotiations that played out on the ground. Furthermore, in seeking new support in the form of PPL investment, ABRO managed to have the best of both worlds for its molecular genetics programme. Private funding not only brought extra income, but also demonstrated the commercial relevance of ABRO research; at the same time, continuous AFRC and MAFF funding offered long-term security unavailable through shorter grant cycles, enabling the organization and its successors to take more risks. This hybrid funding arrangement did come at a cost, however, as multiple sponsors often advanced conflicting agendas, and the Roslin Institute had to spend much energy balancing those in the early 1990s.
In terms of the history of British science and its funding, the case of ABRO highlights both continuities and changes in the 1980s. Developed in line with Thatcherite ideals, privatization and the search for commercial funding were novel features that have left a deep imprint in the life sciences. At the same time, this story cannot be reduced to the diverse and often conflicting policies of Thatcher's governments. Distributed actors at various levels, from research councils to journalists, shaped the outcomes. Many driving factors originated in the 1970s policy decisions, from the Rothschild reforms to the enthusiasm about biotechnology that was sustained in the 1980s. The strategy of embracing novel technology as a way out of a funding crisis pre-dated the 1980s cuts. These cuts were themselves not always a clear policy, but sometimes stemmed from changing accounting mechanisms. Finally, local factors made a difference: ABRO's resistance, its newly entrepreneurial outlook, its ability to benefit from Scottish developments, and internal tensions present within the organization.
728 Dmitriy Myelnikov
